What if cancer treatment could be tailored not just to a diagnosis, but to you, your unique biology, history, and biomarkers?

In this episode of Lightning RX, host Colette Nataf sits down with Nadav Weinberg, Chief Commercial Officer at Velsera, to explore how precision medicine is transforming healthcare. Velsera acts as the “connective tissue” of precision medicine, bridging labs, bioinformatics, and data ecosystems to enable personalized treatment for patients.

Nadav shares insights from scaling multiple companies, including two unicorns and four successful exits, bringing his B2B SaaS growth expertise into the healthcare space. He breaks down:

What You’ll Learn:

• How next-generation sequencing (NGS) data powers patient-specific treatments in oncology
• Why interoperability across labs, providers, and pharma is the missing piece in U.S. healthcare
• How Velsera supports both lab pipelines and large-scale bioinformatic research
• The trust, compliance, and partnerships that helped secure early government contracts
• Lessons on scaling from zero to one, building credibility, and setting the right culture in high-growth companies
• Why aligning product-market fit, customer trust, and scalable infrastructure is critical in healthtech

💡 Golden Nugget:

“Innovation is not just about the science, it’s about connecting the ecosystem, earning trust, and scaling responsibly.”

Connect with Nadav Weinberg

• LinkedIn: linkedin.com/in/nadavweinberg

Connect with the Show:

• LinkedIn
• Website
• Spotify
• Amazon Music
• iHeart

Subscribe on Spotify, Apple Podcasts, or your favorite platform.

If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!